LG’s Utropin adds indication for SGA

Published: 2008-06-18 06:56:00

Updated: 2008-06-18 06:56:00

LG Life Sciences says the Korea Food and Drug Administration has recently approved an additional indication of Utropin, a growth hormone, for the treatment of small for gestational age (SGA).

SGA is a term used to describe a baby who is smaller than the usual amount for the number of weeks of ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK